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REFLECTIONS FROM THE OUTGOING PRESIDENT
The Global Burden of Disease (GBD) Study is a programme of disease burden that assesses mortality and disability from major 
diseases, injuries, and risk factors.(1) It allows for systematic quantification of prevalence, morbidity, and mortality for hundreds of 
diseases, injuries and risk factors of global health importance, and allows for comparison between countries and regions. It has thus 
been used extensively to inform policy and set priorities, and most importantly to understand the changing health challenges facing 
people across the world. The GBD has condensed ICD-10 causes of death into 3 groups: (I) Communicable diseases (e.g. tuberculosis, 
pneumonia, diarrhoea, malaria, measles); Maternal and perinatal causes (e.g. maternal haemorrhage, birth trauma); and Nutritional 
conditions (e.g. protein-energy malnutrition). (2) Non-communicable diseases (e.g. cancer, diabetes, heart disease and asthma). 
(3) External causes of mortality (e.g. accidents, homicide and suicide). The South African Statistical Bureau (Stats SA) recently released 
the mortality and causes of death in South Africa, 2016, with some particularly interesting findings for the cardiovascular community.(2) 
Figure 1 shows the pattern observed over the past 7 years in South Africa (2011 - 2016), with a clear shift to deaths occurring mainly 
as a result of non-communicable diseases. Non-communicable disease is now clearly the most common cause of mortality (and no 
doubt morbidity) and is on the increase, while communicable disease is in steady decline. Although the single major cause of death 
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1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
  Group I 29.7 32.9 35.3 38.2 40.5 43.7 45.6 46.9 48.1 47.7 46.9 47.2 45.7 44.5 41.5 39.2 38.2 36.4 33.3 31.3
  Group II 53.3 52.1 50.7 49.9 48.5 46.0 44.9 43.9 42.9 43.6 44.1 43.8 45.6 46.6 49.3 50.9 51.4 52.9 55.5 57.4
  Group III 17.0 15.1 14.0 12.0 11.1 10.3 9.5 9.2 9.0 8.7 9.0 9.0 8.7 8.9 9.1 9.9 10.4 10.7 11.2 11.2
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FIGURE 1: Percentage distribution of deaths by group type and year of death, 1997 - 2016.*
* Data for 1997 - 2015 have been updated with late registrations/delayed death notification forms processed in 2016/2017. Redistribution ill-defined diseases (R00 - R99) 
proportionately to causes in Group I and Group II.
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remains tuberculosis, cardiovascular disease occupies the third position – with an increase from 
fourth position in 2015 (Figure 2). How do we as an association respond to these realities?
I started writing this editorial a week before the devastating loss of the President of the 
South African Heart Association 2008 - 2010, Prof Bongani Mayosi, and considering the future 
of cardiovascular disease in our country without undoubtedly the greatest scientific mind in 
our community. This has been challenging, but in writing, I am reminded of our very last con-
versation – his vision for an end to cardiovascular diseases of the poor.(3,4)
It is clear to me that our role as an association in the next decade needs to focus on our end 
game – to provide a leadership role in the prevention, detection and response to the huge 
public health threat of cardiovascular disease in this country, and in so doing preventing pre-
mature CVD deaths in all age groups. How as an association are we to do this? I believe we 
should be attacking this on 5 major fronts:
Science 
Our association currently convenes the largest national meeting at our annual congress each 
year and is intricately involved in our special interest groups’ educational activities such as 
AfricaPCR. These meetings showcase science from our established and emerging clinician 
scientists, as well as that from allied and associated professions. In addition, SA Heart® provides 
small research grants for scientific endeavours. However, we are aware of large numbers of 
publications from the communicable disease community, in comparison to the cardiovascular 
community. In some cycles, we have no applications for our research awards, and in some 
congresses fewer abstracts from fellows than we would like to see. As an association, we need 
to lead in science, and we need to empower and support scientific endeavours and provide 
Top 10 leading underlying causes of death
2015 2016
FIGURE 2: Specifi c causes of death in South Africa 2015/2016.
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Liesl Zühlke direction for the academic project. This needs to be rooted in our context, the needs of 
South Africa, and has to be inclusive and growing and promoting a diverse group of 
researchers.(5) I believe we should lobby for significant funding for research into CVD and 
continue to encourage partnerships for research, coordination and consolidation of research 
initiatives.
Human investment
In 2016, several key members of our association and community published a report of the deep 
concerns around human investment within cardiology, paediatric cardiology, and cardiac sur-
geons.(6) In the following years, we do note some improvement in the numbers of graduating 
cardiologists as well as the creation of a few new posts around the country. However, we also 
note with concern reports of severe inadequacies in certain areas. Cecelia Makawane Hospital, 
rebuilt to great acclaim, has not yet been equipped with a modern echo machine for the 
paediatric cardiology unit, for example. There are still 4 provinces with no specialised paediatric 
cardiology services. As an association, we will need to step up into a strong position to highlight 
these inadequacies and the effect they have on our patients and practice – and as far as possible 
consider, promote and provide evidence-based solutions to policy-makers and politicians.
Service
One of the quotations we heard this past week was “The purpose of life is to live a life of 
purpose”. Our association was constituted to represent the professional interests of all cardi-
ologists and cardio-thoracic surgeons in the country, and on our website we declare that 
SA Heart® is there to represent, promote and protect the professional interests of cardi-
ologists and cardiac surgeons, as well as promote public welfare by education directed at the 
prevention and treatment of diseases of the cardiovascular system. All of these are important 
and needed; however, it is time to move our association beyond our own professional and 
personal interests and engage more completely and fully into community-level service outside of 
our professional responsibilities. We can take our example from associations such as the 
European Society of Cardiology who support outreach and foundation initiatives in many 
countries. This may be seen as premature in a young association, but we remain part of the 
African continent, with many parts of our country and continent not as blessed with resources 
as we are. It is time to link with units that have not had large research endeavours when we 
consider joint applications, and it is appropriate to consider how we can partner with hospitals 
with less equipment and fewer projects and initiatives that go beyond professional interests, 
and consider how we link our positions and associations to service. It was clear to me when I 
became President that there was not a good understanding in our country of what SA Heart® 
was. We have attempted to ensure wider visibility and a bigger media presence; however, the 
issue of what we do and what we represent is the next major frontier – and this needs to be 
tackled directly.
Transformation
Prof Mayosi was the first SA Heart® President of colour and thus set the bar for transformation 
within our community. These past 2 years were the first time that the South Africa Heart 
Association was led by a paediatric cardiologist. We also see that our executive, special interest 
groups and board members reflect the diverse nature of our community and cardiovascular 
practitioners. This represents real progress, but this needs to continue unabated. Women 
remain in the minority, and representation from private, public and research is not always ideal. 
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The relationship with special interest groups and allied professionals should be more com-
plementary than competitive, and multidisciplinary initiatives should be encouraged. We should 
also work very closely with civil society and patient and family support groups to disseminate 
our messages for prevention, promotion and cardiovascular wellness – as the philosophy of inte-
grating patients into the discourse around their health becomes not only stronger, but based 
in evidence.
Professionalism and fi nancial accountability
In general, associations and societies have become professionally run and organised. We, in 
SA Heart® have had significant financial challenges over the last years and now also face a 
renewed financial and sponsorship climate. We have had to take some difficult decisions in this 
context over past years, and this will also continue over the next terms. The possibility to carry 
out the first 3 thrusts adequately will also largely depend on funding, and thus this does repre-
sent 1 of our major challenges. Again, this has called for innovative and inventive thinking, dif-
ferent approaches to our aims of supporting students, fellows and faculty (this year we were the 
recipient of a major NRF award and have been able to fully support 18 African fellows to attend 
our meeting and also almost 30 South African fellows), and different links with industry. As we 
look forward to 2019 and our joint meeting with PASCAR, this will no doubt also require 
careful consideration and thinking. The key is to remain fiscally prudent, but strong in our vision 
to be an association that supports its members, the community and science – while remaining 
true to our position as a South African and African association. 
These are my personal reflections, and I hope they will resonate with the new leadership and 
with the leadership in years to come. I of course will continue to support these and other 
endeavours into the future – but I can also imagine that David Jankelow and his team may have 
other priorities and thoughts. It has been an honour to serve in this capacity over the past 2 
years, and I wish SA Heart® only the best in years to come. I look forward to watching our asso-
ciation become one rooted in science and service, with a large and diverse group of individuals 
heavily involved in a professional and accountable association.
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